Where Pliant Therapeutics Stands With Analysts
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish and somewhat bullish ratings for Pliant Therapeutics (NASDAQ:PLRX) in the last quarter. The average price target is $52.38, indicating a significant upside from the current price of $16.945. The average has increased by 1.37% from the previous target of $51.67.
August 22, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pliant Therapeutics has received positive ratings from analysts, with a significant upside indicated in the price target.
The bullish and somewhat bullish ratings from analysts indicate a positive outlook for Pliant Therapeutics. The significant increase in the average price target suggests a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100